Tag: New York Stock Exchange (NYSE)
NYSE delists Invacare
April 11, 2023HME News Staff
ELYRIA, Ohio – The New York Stock Exchange has delisted Invacare. The NYSE filed a Form 25 with the U.S. Securities and Exchange Commission on Feb. 16 to delist the company’s common shares, with the change taking effect 10 days later. The delisting will be in effect for 90 days or such shorter period as the SEC may determine. Trading of Invacare’s common stock now occurs on the OTC Pink Market under the symbol IVCRQ. As of April 10, the company was trading there for 0.0158, with...
Invacare receives notice of noncompliance
September 30, 2022HME News Staff
ELYRIA, Ohio – Invacare announced on Sept. 29 that it has received notice from the New York Stock Exchange that the company is not in compliance because the average closing price of the company’s common shares was less than $1 per share over a consecutive 30 trading-day period.
The notice does not result in the immediate delisting of the company’s common shares from the NYSE.
Invacare plans to notify the NYSE by Oct. 7 that it intends to cure the stock price deficiency...
Chart Industries to move to NYSE
January 19, 2021HME News Staff
ATLANTA – Chart Industries announced Jan. 18 that it plans to transfer the listing of its common stock to the New York Stock Exchange from the NASDAQ stock exchange effective Feb. 1, 2021. The stock will continue to trade under the ticker symbol GTLS and will continue to trade on the NASDAQ until the transfer is complete. “We are pleased to join the NYSE, the world’s largest stock exchange with world-class listed companies, to further reach global investors and shareholders,”...
ResMed CEO to ring Opening Bell
September 27, 2019HME News Staff
SAN DIEGO - ResMed CEO Mick Farrell will ring the Opening Bell at the New York Stock Exchange on Sept. 30 to celebrate 20 years of being listed on the NYSE and to commemorate ResMed's 30th anniversary. Founded in 1989 as ResCare, ResMed today has more than 4.5 billion nights of medical sleep and respiratory care data and more than 10 million 100% cloud connectible devices. “From a single A$1.25 million investment, ResMed has transformed into a A$28 billion (US$19 billion) connected health...
Liberator claims no knowledge of unusual market activity
January 23, 2014HME News Staff
STUART, Fla. - Liberator Medical doesn't know why its stock prices fell sharply the morning of Tuesday, Jan. 21, according to a release. The New York Stock Exchange (NYSE), in accordance with its usual practice, contacted Liberator when the company's stocks fell from $5.9942 to $4.18 in a matter of hours of trading. While its policy, in general, is not to comment on unusual market activity, Liberator said “it knows of no event or series of events that could have caused such market activity,”...
Liberator Medical Supply moves to Big Board
December 6, 2013Theresa Flaherty, Managing Editor
STUART, Fla. - Liberator Medical Supply began trading on the New York Stock Exchange (NYSE) Nov. 20, a major milestone for the company, say analysts.
The listing should give the company a shot in the arm, they say.
“It can take advantage of opportunities to grow the business and perform for a greater number of shareholders,” said Jonathan Sadock, managing partner/CEO of Paragon Ventures. “It will be interesting to see how the public markets value the company going forward.”
Liberator...
Liberator stock heads to NYSE
November 18, 2013HME News Staff
STUART, Fla. - Common stock of Liberator Medical Holdings has been approved to trade on the New York Stock Exchange starting Nov. 20, the company announced Nov. 18. Stock will trade under LBMH. “We are confident that our leading market positions and strong customer relationships, combined with the increased visibility of being listed on the NYSE, will help enhance value for all stakeholders,” stated Mark Libratore, Liberator CEO, in a release. Liberator, whose products include diabetic...